Respiratory Disease Testing Market by Test Type and Geography - Forecast and Analysis 2021-2025

  • Published: Sep 2021
  • Pages: 120
  • SKU: IRTNTR71023
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The respiratory disease testing market has the potential to grow by USD 3.52 billion during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 7.01%.

This respiratory disease testing market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by test type (imaging tests, mechanical tests, and in-vitro diagnostic tests) and geography (North America, Europe, Asia, and ROW). The respiratory disease testing market report also offers information on several market vendors, including Cepheid Inc., COSMED Srl, F. Hoffmann-La Roche Ltd., Koninklijke Philips NV, NDD Medical Technologies, Nihon Kohden Corp., ResMed Inc., Seegene Inc., Smiths Group Plc, and Vyaire Medical Inc. among others.

What will the Respiratory Disease Testing Market Size be in 2021?

Respiratory-Disease-Testing-Market-Market-Size-2020-2025

Browse TOC and LoE with selected illustrations and example pages of Respiratory Disease Testing Market

 Get Your FREE Sample Now!

Respiratory Disease Testing Market: Key Drivers and Trends

The rising prevalence of COPD is notably driving the respiratory disease testing diagnostics growth, although factors such as competitive pricing between global and local vendors may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the respiratory disease testing industry. The holistic analysis of the drivers will help in predicting end goals and refining marketing strategies to gain a competitive edge.

This respiratory disease testing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Respiratory Disease Testing Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Cepheid Inc.
  • COSMED Srl
  • F. Hoffmann-La Roche Ltd.
  • Koninklijke Philips NV
  • NDD Medical Technologies
  • Nihon Kohden Corp.
  • ResMed Inc.
  • Seegene Inc.
  • Smiths Group Plc
  • Vyaire Medical Inc.

 

The vendor landscape of the respiratory disease testing market entails successful business strategies deployed by the vendors. The respiratory disease diagnostics market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the respiratory disease testing market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Respiratory Disease Testing Market?

Respiratory-Disease-Testing-Market-Market-Share-by-Region-2020-2025

For more insights on the market share of various regions Request for a FREE sample now!

30% of the market’s growth will originate from Asia during the forecast period. China and Japan are the key markets for respiratory disease testing in Asia. 

The report offers an up-to-date analysis of the geographical composition of the market. Asia has been recording a significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. The initiatives by government and non-profit organizations to diagnose RSV will facilitate the respiratory disease testing market growth in Asia over the forecast period. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors.

What are the Revenue-generating Test Type Segments in the Respiratory Disease Testing Market?

Respiratory-Disease-Testing-Market-Market-Share-by-Test Type-2020-2025

To gain further insights on the market contribution of various segments Request for a FREE sample

The respiratory disease testing market share growth by the imaging tests segment has been significant. An imaging test allows doctors to see the functioning of the different organs inside the human body. The latest developments in imaging devices are expected to drive the demand for ultrasound and other imaging tests during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the respiratory disease diagnostics market size. Furthermore, our analysts have indicated actionable market insights on post COVID-19 impact on each segment, which is crucial to predict change in consumer demand.

Respiratory Disease Testing Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 7.01%

Market growth 2021-2025

$ 3.52 billion

Market structure

Fragmented

YoY growth (%)

8.49

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

Asia at 30%

Key consumer countries

US, China, UK, Germany, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Cepheid Inc., COSMED Srl, F. Hoffmann-La Roche Ltd., Koninklijke Philips NV, NDD Medical Technologies, Nihon Kohden Corp., ResMed Inc., Seegene Inc., Smiths Group Plc, and Vyaire Medical Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Factors Covered in this Respiratory Disease Testing Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive respiratory disease testing market growth during the next five years
  • Precise estimation of the respiratory disease testing market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the respiratory disease diagnostics industry across North America, Europe, Asia, and ROW 
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of respiratory disease diagnostics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Test type

    • Market segments
    • Comparison by Test type
    • Imaging tests - Market size and forecast 2020-2025
    • Mechanical tests - Market size and forecast 2020-2025
    • In-vitro diagnostic tests - Market size and forecast 2020-2025
    • Market opportunity by Test type

    Customer landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2020-2025
      • Europe - Market size and forecast 2020-2025
      • Asia - Market size and forecast 2020-2025
      • ROW - Market size and forecast 2020-2025
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Overview
      • Landscape disruption

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • Cepheid Inc.
      • COSMED Srl
      • F. Hoffmann-La Roche Ltd.
      • Koninklijke Philips NV
      • NDD Medical Technologies
      • Nihon Kohden Corp.
      • ResMed Inc.
      • Seegene Inc.
      • Smiths Group Plc
      • Vyaire Medical Inc.

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your FREE sample now!
      The respiratory disease testing market growth will increase by $3515.84 million during 2020-2025.
      The respiratory disease testing market is expected to grow at a CAGR of 7.01% during 2020-2025.
      Technavio has segmented the respiratory disease testing market by other1 (Imaging tests, Mechanical tests, and In-vitro diagnostic tests) and geographic (North America, Europe, Asia, and ROW).
      Cepheid Inc., COSMED Srl, F. Hoffmann-La Roche Ltd., Koninklijke Philips NV, NDD Medical Technologies, Nihon Kohden Corp., ResMed Inc., Seegene Inc., Smiths Group Plc, Vyaire Medical Inc. are a few of the key vendors in the respiratory disease testing market.
      Asia will register the highest growth rate of 30.43% among the other regions. Therefore, the respiratory disease testing market in Asia is expected to garner significant business opportunities for the vendors during the forecast period.
      The key factors driving the respiratory disease testing market growth are:
      • Rising prevalence of COPD
      The respiratory disease testing market vendors should focus on grabbing business opportunities from the segment as it accounted for the largest market share in the base year.
      Safe and Secure SSL Encrypted
      Technavio

      Single User:

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Want to customize this report?

      This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

      We offer $1000 worth of FREE customization at the time of purchase
      Technavio
      Enquire Before Buying
      1. Home
      2. Health Care
      3. Published Report
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>